Glycoproteins produced and secreted from specific cells and tissues are associated with several diseases and emerge as typical biomarkers to provide useful information in cancer diagnosis considering their abnormal expression levels. In this work, we design a universal method to achieve the accurate and sensitive analysis of tumor-associated glycoprotein biomarkers based on both carbohydrate recognition and protein recognition at the same protein surface. The byproduct of dual recognition-induced proximity amplification, pyrophosphate, triggers the disassembly of methylene blue-encapsulated metal-organic frameworks, MB@ZIF-90. As a result, methylene blue molecules are released to arouse amplified electrochemical responses for glycoprotein analysis. Experimental results demonstrate the high-accuracy analysis of carcinoembryonic antigen, a typical glycoprotein biomarker in cancer diagnosis, in a linear range of 0.001-100 ng mL -1 with a low limit of detection of 0.419 pg mL -1 . The method also displays satisfactory specificity and recoveries in complex serum samples and proves good versatility by adopting two other tumor-associated glycoprotein biomarkers, α-fetoprotein and mucin-1, as the targets. Therefore, this work provides a valuable tool for the analysis of glycoprotein biomarkers, which may be of great potential in early warning of malignant tumors in clinical applications.
Keyphrases
- label free
- papillary thyroid
- gold nanoparticles
- induced apoptosis
- gene expression
- healthcare
- binding protein
- squamous cell
- squamous cell carcinoma
- nucleic acid
- molecularly imprinted
- high resolution
- risk assessment
- signaling pathway
- endoplasmic reticulum stress
- climate change
- cell death
- endothelial cells
- lymph node metastasis
- childhood cancer
- loop mediated isothermal amplification
- liquid chromatography
- human health
- solid phase extraction
- pi k akt